Form D — Cadrenal Therapeutics, Inc.
0001213900-26-078373 · filed Jul 15, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $8,843,849
- Reported amount sold
- $8,843,849
- Minimum investment
- $0
- Investors
- 1
- Sales commission
- $315,000
- Finders' fees
- $0
Issuer
- Name
- Cadrenal Therapeutics, Inc.
- CIK
- 1937993
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 822 A1A NORTH, SUITE 306
PONTE VEDRA, FL 32082 - Phone
- (904) 300-0701
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Quang X. Pham · Executive OfficerPonte Vedra, FL Find on LinkedIn ↗
-
John P. Sharp · Executive OfficerPonte Vedra, FL Find on LinkedIn ↗
-
James J. Ferguson · Executive OfficerPonte Vedra, FL Find on LinkedIn ↗
-
Jeffrey S. Cole · Executive OfficerPonte Vedra, FL Find on LinkedIn ↗
-
Lee Golden · DirectorPonte Vedra, FL Find on LinkedIn ↗
-
John R. Murphy · DirectorPonte Vedra, FL Find on LinkedIn ↗
-
Glynn Wilson · DirectorPonte Vedra, FL Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗